| |
| |
|
| Insider
Information: |
Tcg Iv Gp, Llc |
| Relationship: |
10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
12,505,341 |
|
|
Indirect Shares
|
8,827,211 |
|
|
| Direct
Value |
$20,183,550 |
|
|
|
Indirect Value
|
$14,773,437 |
|
|
| Total
Shares |
21,332,552 |
|
|
| Total
Value |
$34,956,988 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ngm Biopharmaceuticals Inc |
NGM |
10% Owner |
2022-06-09 |
11,103,333 |
2022-06-09 |
7,040,041 |
Premium* |
|
|
Rapt Therapeutics, Inc. |
RAPT |
10% Owner |
2022-05-25 |
1,402,008 |
2022-05-25 |
1,787,170 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RAPT |
Rapt Therapeutics, Inc. |
10% Owner |
– – • |
2022-05-10 |
4 |
B |
$10.67 |
$13,339,375 |
I/I |
1,250,000 |
41,250 |
1.5 |
- |
|
| RAPT |
Rapt Therapeutics, Inc. |
10% Owner |
– – • |
2022-05-23 |
4 |
B |
$12.50 |
$127,943 |
I/I |
10,236 |
41,588 |
1.5 |
- |
|
| RAPT |
Rapt Therapeutics, Inc. |
10% Owner |
– – • |
2022-05-24 |
4 |
B |
$12.00 |
$195,802 |
I/I |
16,314 |
42,126 |
1.5 |
- |
|
| RAPT |
Rapt Therapeutics, Inc. |
10% Owner |
– – • |
2022-05-25 |
4 |
B |
$12.45 |
$23,664 |
I/I |
1,900 |
42,189 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-01-24 |
4 |
B |
$0.00 |
$0 |
I/I |
250,000 |
8,250 |
1.42 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-01-25 |
4 |
B |
$0.00 |
$0 |
I/I |
599,701 |
28,041 |
1.42 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-09 |
4 |
B |
$10.79 |
$897,699 |
I/I |
83,175 |
30,786 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-10 |
4 |
B |
$11.36 |
$355,283 |
I/I |
31,265 |
31,818 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-11 |
4 |
B |
$11.23 |
$935,354 |
I/I |
83,175 |
34,563 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-12 |
4 |
B |
$11.62 |
$966,678 |
I/I |
83,175 |
37,308 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-13 |
4 |
B |
$0.00 |
$0 |
I/I |
129,365 |
41,577 |
1.42 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-16 |
4 |
B |
$12.90 |
$427,891 |
I/I |
33,166 |
42,671 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-17 |
4 |
B |
$13.42 |
$1,194,779 |
I/I |
89,049 |
45,610 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-18 |
4 |
B |
$13.20 |
$827,224 |
I/I |
62,650 |
47,677 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-19 |
4 |
B |
$13.25 |
$273,922 |
I/I |
20,666 |
48,359 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-20 |
4 |
B |
$13.48 |
$256,533 |
I/I |
19,034 |
48,987 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-24 |
4 |
B |
$13.37 |
$238,325 |
I/I |
17,828 |
49,575 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-25 |
4 |
B |
$13.43 |
$581,624 |
I/I |
43,292 |
51,004 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-26 |
4 |
B |
$13.49 |
$272,582 |
I/I |
20,201 |
51,671 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-27 |
4 |
B |
$13.45 |
$36,453 |
I/I |
2,710 |
51,760 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-05-31 |
4 |
B |
$13.47 |
$832,267 |
I/I |
61,806 |
53,800 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-06-01 |
4 |
B |
$13.45 |
$1,237,400 |
I/I |
92,000 |
56,836 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-06-02 |
4 |
B |
$13.03 |
$445,739 |
I/I |
34,200 |
57,965 |
1.5 |
- |
|
| NGM |
Ngm Biopharmaceuticals In... |
10% Owner |
– – • |
2022-06-09 |
4 |
B |
$13.50 |
$13,286,174 |
I/I |
984,161 |
90,442 |
1.5 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
